Ecolab Inc. – Consensus Indicates Potential 8.0% Upside
Ecolab Inc. with ticker code (ECL) now have 18 analysts in total covering the stock. The consensus rating is ''Hold''. The range between the high target price and low target price is between 200 and 163 calculating the mean target price we have 179.89. Now with the previous closing price of 166.5 this now indicates there is a potential upside of 8.0%. The 50 day moving average now sits at 159.53 and the 200 moving average now moves to 187.69. The market capitalisation for the company is $47,050m. Company Website: https:||www.ecolab.com [stock_market_widget type="chart" template="basic" color="green" assets="ECL" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $50,834m based on the market concensus. Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional Specialty, and Global Healthcare Life Sciences segments.
Ecolab Inc. – Consensus Indicates Potential 8.0% Upside
Ecolab Inc. with ticker code (ECL) now have 18 analysts in total covering the stock. The consensus rating is ''Hold''. The range between the high target price and low target price is between 200 and 163 calculating the mean target price we have 179.89. Now with the previous closing price of 166.5 this now indicates there is a potential upside of 8.0%. The 50 day moving average now sits at 159.53 and the 200 moving average now moves to 187.69. The market capitalisation for the company is $47,050m. Company Website: https:||www.ecolab.com [stock_market_widget type="chart" template="basic" color="green" assets="ECL" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $50,834m based on the market concensus. Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional Specialty, and Global Healthcare Life Sciences segments.